Both JAK/STAT3 and MAPK/ERK signalling pathways were found to mediate the observed effects of IL-6 on HPV-negative cell behaviour; however, only the MAPK/ERK pathway was activated by IL-6 treatment in HPV-positive HNSCC (Figure 3A–G). The gene discussed is STAT3; the disease is head and neck squamous cell carcinoma.